The role of the unfolded protein response in arrhythmias

Channels
Man Liu, Samuel C Dudley

Abstract

Human heart failure is characterized by arrhythmogenic electrical remodeling consisting mostly of ion channel downregulations. Reversing these downregulations is a logical approach to antiarrhythmic therapy, but understanding the pathophysiological mechanisms of the reduced currents is crucial for finding the proper treatments. The unfolded protein response (UPR) is activated by endoplasmic reticulum (ER) stress and has been found to play pivotal roles in different diseases including neurodegenerative diseases, diabetes mellitus, and heart disease. Recently, the UPR is reported to regulate multiple cardiac ion channels, contributing to arrhythmias in heart disease. In this review, we will discuss which UPR modulators and effectors could be involved in regulation of cardiac ion channels in heart disease, and how the understanding of these regulating mechanisms may lead to new antiarrhythmic therapeutics that lack the proarrhythmic risk of current ion channel blocking therapies.

References

May 23, 2001·The Journal of Biological Chemistry·C A Ufret-VincentyL F Santana
Oct 31, 2001·Photochemistry and Photobiology·D P Valenzeno, M Tarr
Aug 16, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Gui-Rong LiStanley Nattel
Apr 3, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Maurizio VitadelloLuisa Gorza
Jul 30, 2003·Circulation·Arie O VerkerkE Etienne Verheijck
Sep 6, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jürgen Borlak, Thomas Thum
Apr 17, 2004·Circulation Research·Barbara Rosati, David McKinnon
Jan 8, 2005·American Journal of Physiology. Heart and Circulatory Physiology·Jochen RoseGordon F Tomaselli
Mar 1, 2005·Journal of Molecular and Cellular Cardiology·Carmen R ValdiviaJonathan C Makielski
Oct 4, 2005·The Journal of Clinical Investigation·Chunyan XuJohn C Reed
Jun 24, 2006·Circulation Research·Donna J ThueraufChristopher C Glembotski
Dec 7, 2007·Journal of Molecular and Cellular Cardiology·Christopher C Glembotski
Apr 9, 2008·Journal of Clinical Biochemistry and Nutrition·Zhenhua LiZhiming Ge
Sep 12, 2009·Circulation Research·Man LiuSamuel C Dudley
Feb 23, 2010·Journal of Molecular and Cellular Cardiology·Tamaki SawadaIssei Komuro
Apr 13, 2010·Journal of Molecular and Cellular Cardiology·Hauhiro TokoIssei Komuro
Jul 10, 2010·Circulation Research·Masafumi Kitakaze, Osamu Tsukamoto
Oct 30, 2010·Circulation Research·Tetsuo MinaminoMasafumi Kitakaze
Nov 3, 2010·Journal of Molecular and Cellular Cardiology·Asli F Ceylan-IsikJun Ren
Nov 13, 2010·Circulation Research·Jody GroenendykMarek Michalak
Jan 15, 2011·BioTechniques·Michael T ForresterJeremy N Rich
Aug 2, 2011·Journal of Molecular and Cellular Cardiology·E P ScholzE Zitron
Aug 2, 2011·American Journal of Physiology. Heart and Circulatory Physiology·Jianping TaoMeng Wei
Oct 8, 2011·Journal of Molecular and Cellular Cardiology·Euy-Myoung JeongSamuel C Dudley
Nov 19, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Christopher M Scull, Ira Tabas
Apr 28, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Modar KassanKhalid Matrougui
Oct 16, 2012·The Journal of Clinical Investigation·Alyssa H Hasty, David G Harrison
Nov 6, 2012·Journal of Molecular and Cellular Cardiology·Man LiuSamuel C Dudley

❮ Previous
Next ❯

Citations

Jul 30, 2021·The Journal of Clinical Investigation·Man LiuSamuel C Dudley

❮ Previous
Next ❯

Methods Mentioned

BETA
protein folding
glycosylation

Related Concepts

Related Feeds

Cardiac Electrophysiology

Cardiac electrophysiology is the study of electrical activities of the heart and includes the assessment, diagnosis, and treatment of cardiac events. Find the latest research on cardiac electrophysiology here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.